Form 4 for SNDX Syndax Pharmaceuticals Inc
Accepted 2025-07-18 00:00:00 ET · period of report 2025-07-16 · accession 0000950170-25-096948 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-18 | 2025-07-16 | SNDX | Goldan Keith A. | CFO | S - Sale | $9.29 | -1,296 | 92.5K | -1% | -$12.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-16 | S | D | 1,296 | $9.29 | 92,450 | D | — | — | (F1) Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. |